These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 31273940)
1. Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience. Barut K; Adrovic A; Sahin S; Tarcin G; Tahaoglu G; Koker O; Yildiz M; Kasapcopur O Int J Rheum Dis; 2019 Sep; 22(9):1661-1669. PubMed ID: 31273940 [TBL] [Abstract][Full Text] [Related]
2. Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis. Schulert GS; Minoia F; Bohnsack J; Cron RQ; Hashad S; KonÉ-Paut I; Kostik M; Lovell D; Maritsi D; Nigrovic PA; Pal P; Ravelli A; Shimizu M; Stanevicha V; Vastert S; Woerner A; de Benedetti F; Grom AA Arthritis Care Res (Hoboken); 2018 Mar; 70(3):409-419. PubMed ID: 28499329 [TBL] [Abstract][Full Text] [Related]
3. Systemic onset juvenile idiopathic arthritis: a single center experience. Sağ E; Uzunoğlu B; Bal F; Sönmez HE; Demir S; Bilginer Y; Özen S Turk J Pediatr; 2019; 61(6):852-858. PubMed ID: 32134578 [TBL] [Abstract][Full Text] [Related]
4. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus. Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530 [TBL] [Abstract][Full Text] [Related]
5. Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry. Horneff G; Schulz AC; Klotsche J; Hospach A; Minden K; Foeldvari I; Trauzeddel R; Ganser G; Weller-Heinemann F; Haas JP Arthritis Res Ther; 2017 Nov; 19(1):256. PubMed ID: 29166924 [TBL] [Abstract][Full Text] [Related]
7. A retrospective study on 158 Thai patients with juvenile idiopathic arthritis followed in a single center over a 15-year period. Vilaiyuk S; Soponkanaporn S; Jaovisidha S; Benjaponpitak S; Manuyakorn W Int J Rheum Dis; 2016 Dec; 19(12):1342-1350. PubMed ID: 26176300 [TBL] [Abstract][Full Text] [Related]
8. Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China. Zou LX; Zhu Y; Sun L; Ma HH; Yang SR; Zeng HS; Xiao JH; Yu HG; Guo L; Xu YP; Lu MP World J Pediatr; 2020 Feb; 16(1):89-98. PubMed ID: 31612427 [TBL] [Abstract][Full Text] [Related]
9. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Minoia F; Davì S; Horne A; Demirkaya E; Bovis F; Li C; Lehmberg K; Weitzman S; Insalaco A; Wouters C; Shenoi S; Espada G; Ozen S; Anton J; Khubchandani R; Russo R; Pal P; Kasapcopur O; Miettunen P; Maritsi D; Merino R; Shakoory B; Alessio M; Chasnyk V; Sanner H; Gao YJ; Huasong Z; Kitoh T; Avcin T; Fischbach M; Frosch M; Grom A; Huber A; Jelusic M; Sawhney S; Uziel Y; Ruperto N; Martini A; Cron RQ; Ravelli A; ; ; ; Arthritis Rheumatol; 2014 Nov; 66(11):3160-9. PubMed ID: 25077692 [TBL] [Abstract][Full Text] [Related]
10. Incidence of herpes zoster infections in juvenile idiopathic arthritis patients. Nimmrich S; Horneff G Rheumatol Int; 2015 Mar; 35(3):465-70. PubMed ID: 25583050 [TBL] [Abstract][Full Text] [Related]
11. The burden of systemic juvenile idiopathic arthritis for patients and caregivers: an international survey and retrospective chart review. Shenoi S; Horneff G; Cidon M; Ramanan AV; Kimura Y; Quartier P; Foeldvari I; Zeft A; Lomax KG; Gregson J; Abma T; Campbell-Hill S; Weiss J; Patel D; Marinsek N; Wulffraat N Clin Exp Rheumatol; 2018; 36(5):920-928. PubMed ID: 29600940 [TBL] [Abstract][Full Text] [Related]
12. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or -6 therapy. Ulu K; Aliyev E; Kılıç Könte E; Tanatar A; Türkmen Ş; Doğantan Ş; Kızıldağ Z; Kasap Demir B; Gezgin Yıldırım D; Otar Yener G; Öztürk K; Baba Ö; Açarı C; Kılbaş G; Taşkın SN; Haşlak F; Çağlayan Ş; Bağlan E; Dundar HA; Başaran Ö; Barut K; Karadağ ŞG; Coşkuner T; Sönmez HE; Yüksel S; Kalyoncu M; Bakkaloğlu SA; Ünsal E; Paç Kısaarslan A; Bilginer Y; Aktay Ayaz N; Kasapçopur Ö; Özen S; Sözeri B Rheumatology (Oxford); 2024 Sep; 63(SI2):SI167-SI172. PubMed ID: 38441301 [TBL] [Abstract][Full Text] [Related]
13. A MASsive attack: a pediatric case of macrophage activation syndrome complicated by DIC as an onset of systemic juvenile idiopathic arthritis successfully treated with anakinra and review of the literature. Maeser A; Biernacka-Zielinska M; Smolewska E Rheumatol Int; 2024 Nov; 44(11):2607-2612. PubMed ID: 38502236 [TBL] [Abstract][Full Text] [Related]
14. Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab. Grom AA; Ilowite NT; Pascual V; Brunner HI; Martini A; Lovell D; Ruperto N; ; Leon K; Lheritier K; Abrams K Arthritis Rheumatol; 2016 Jan; 68(1):218-28. PubMed ID: 26314396 [TBL] [Abstract][Full Text] [Related]
15. Systemic Juvenile Idiopathic Arthritis. Lee JJY; Schneider R Pediatr Clin North Am; 2018 Aug; 65(4):691-709. PubMed ID: 30031494 [TBL] [Abstract][Full Text] [Related]
16. Systemic Juvenile Idiopathic Arthritis and Secondary Macrophage Activation Syndrome in Latvia from 2009 to 2020: A Nationwide Retrospective Study. Lukjanoviča K; Šlēziņa I; Dāvidsone Z; Šantere R; Budarina K; Staņēviča V Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109756 [No Abstract] [Full Text] [Related]
17. Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab. Yokota S; Itoh Y; Morio T; Sumitomo N; Daimaru K; Minota S J Rheumatol; 2015 Apr; 42(4):712-22. PubMed ID: 25684767 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of clinical outcomes in systemic juvenile idiopathic arthritis patients treated with biological agents in Turkey: the TURSIS study. Sozeri B; Demir F; Barut K; Atalay E; Pac Kisaarslan A; Özdel S; Altuğ Gücenmez Ö; Makay B; Aktay Ayaz N; Haşlak F; Sağ E; Yıldız M; Kaya Akça Ü; Adroviç A; Bilginer Y; Poyrazoğlu H; Ünsal E; Kasapçopur Ö; Özen S Clin Exp Rheumatol; 2024 Jan; 42(1):194-201. PubMed ID: 37497697 [TBL] [Abstract][Full Text] [Related]
19. Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease. Ruscitti P; Natoli V; Consolaro A; Caorsi R; Rosina S; Giancane G; Naddei R; Di Cola I; Di Muzio C; Berardicurti O; Iacono D; Pantano I; Rozza G; Rossi S; De Stefano L; Balduzzi S; Vitale A; Caso F; Costa L; Prete M; Navarini L; Iagnocco A; Atzeni F; Guggino G; Perosa F; Cantarini L; Frediani B; Montecucco C; Ciccia F; Cipriani P; Gattorno M; Giacomelli R; Ravelli A Rheumatology (Oxford); 2022 Oct; 61(10):4124-4129. PubMed ID: 35078234 [TBL] [Abstract][Full Text] [Related]
20. The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013. Janow G; Schanberg LE; Setoguchi S; Hasselblad V; Mellins ED; Schneider R; Kimura Y; J Rheumatol; 2016 Sep; 43(9):1755-62. PubMed ID: 27307527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]